Business
Novo Nordisk secures new licensing deal
Novo Nordisk has struck its second licensing agreement since a poor market reception, signaling ongoing efforts to diversify its business.
Coverage timeline — 1 article
MarketWatch
Novo Nordisk on Tuesday struck its second licensing deal since receiving a poor reception from investors after presenting its long-term strategy.
2026-09-29 09:45 UTC